Martingale Asset Management’s American Renal Associates Holdings ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-63,806
Closed -$404K – 1051
2019
Q3
$404K Sell
63,806
-28,022
-31% -$209K ﹤0.01% 906
2019
Q2
$684K Hold
91,828
– – 0.01% 835
2019
Q1
$564K Buy
91,828
+26,400
+40% +$306K 0.01% 870
2018
Q4
$754K Sell
65,428
-2,500
-4% -$42.7K 0.01% 796
2018
Q3
$1.47M Buy
67,928
+603
+0.9% +$11.4K 0.02% 630
2018
Q2
$1.06M Sell
67,325
-7,700
-10% -$121K 0.01% 730
2018
Q1
$1.42M Sell
75,025
-1,200
-2% -$23.7K 0.02% 644
2017
Q4
$1.33M Buy
76,225
+9,307
+14% +$128K 0.02% 648
2017
Q3
$1M Buy
66,918
+31,501
+89% +$495K 0.01% 727
2017
Q2
$657K Buy
35,417
+13,412
+61% +$233K 0.01% 784
2017
Q1
$372K Buy
+22,005
New +$439K 0.01% 850

Other funds holding ARA

Martingale Asset Management's ARA Position: Q4 2019 in Review

Martingale Asset Management sold out of American Renal Associates Holdings (ARA) in Q4 2019, closing a stake of 63,806 shares — an estimated $404K sold.

Martingale Asset Management first reported a position in ARA in Q1 2017 and held it in 11 quarters. The position peaked at $1.47M in Q3 2018. 66 funds tracked by Wall St. Rank hold ARA as of Q4 2019.

  • Martingale Asset Management reported no remaining American Renal Associates Holdings position as of Q4 2019 after selling out during the quarter.
  • Martingale Asset Management sold 63,806 American Renal Associates Holdings shares in Q4 2019, an estimated $404K.
  • Martingale Asset Management first reported a position in American Renal Associates Holdings in Q1 2017 and held it in 11 quarters.
  • Martingale Asset Management's American Renal Associates Holdings position peaked at $1.47M in Q3 2018.
  • 66 funds tracked by Wall St. Rank held American Renal Associates Holdings as of Q4 2019.

Based on Martingale Asset Management's 13F filing for Q4 2019, filed 10 Feb 2020.